Overview
Observational study. Participants of the FRASNET study (9th March 2017, Protocol No. 24/INT/2017) who were evaluated in 2016 and 2017 will be contacted to be re-evaluated with multidimensional visits as part of the present study in order to assess trajectories and biomarkers of frailty and sarcopenia. Moreover, are going to evaluate with the same multidimensional visits patients with mild cognitive impairment and dementia followed up at the Neurologic Unit of the San Raffaele Hospital.
Eligibility
Inclusion Criteria:
- Having participated in the FRASNET study or being a patient with mild cognitive impairment or dementia followed up at the Neurologic Unit of the San Raffaele Hospital
- Ability to sign written informed consent
- > 18 years old
Exclusion Criteria:
- Life expectancy < 6 months
- Unwillingness to participate in the study
- Unstable clinical disease(for ex. serious acute pathologies)